Redhawk Wealth Advisors Inc. Increases Holdings in SPDR S&P Biotech ETF $XBI

Redhawk Wealth Advisors Inc. increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 18.1% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 23,790 shares of the exchange traded fund’s stock after acquiring an additional 3,651 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,765,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Wealth Management Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter worth $547,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 106.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after acquiring an additional 13,729 shares during the last quarter. Keystone Investors PTE Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $12,022,000. Greystone Financial Group LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $658,000. Finally, Lalia Capital LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $12,193,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $158.03 on Tuesday. The company has a market cap of $10.32 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52-week low of $84.81 and a 52-week high of $165.71. The firm’s fifty day moving average is $148.49 and its two-hundred day moving average is $135.64.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.